H-1B visa programme faces onslaught of Congressional bills

March 9, 2017

Washington, Mar 9: With the Trump administration seriously mulling H-1B visa reforms, at least half a dozen bills have been tabled in the US House of Representatives and the Senate, contending that the programme that is popular among Indian IT firms eats into American jobs.

visaAuthors of all these bills from both the Republican and the Democratic parties believe that H-1B work visas, which are highly popular among Indian techies and Indian IT companies, tend to replace American workers.

Even though this argument is disputed by research scholars, economists and Silicon Valley executives, these legislations are based on the premise that Indian techies are eating into American jobs.

In less than a week of Trump being sworn in as the 45th US President, Republican Senator Chuck Grassley, and Assistant Senate Minority Leader Dick Durbin, introduced the "H-1B and L-1 Visa Reform Act" to prioritise American workers and restore fairness in visa programmes for skilled workers.

Grassley is Chairman of the powerful Senate Judiciary Committee. Among other things, the H1-B reform bill proposes to eliminate the lottery system and give foreign students educated in the US priority on visas.

The bill would prohibit companies with more than 50 employees, of which at least half are H-1B or L-1 holders, from hiring additional H-1B employees.

It also explicitly prohibits the replacement of American workers by H-1B or L-1 visa holders. The bill among other things would also crackdown on outsourcing companies that import large numbers of H-1B and L-1 workers for temporary training purposes only to send the workers back to their home countries to do the same job.

Specifically, it would prohibit companies with more than 50 employees of which at least half are H-1B or L-1 holders, from hiring additional H-1B employees, a statement said.

It explicitly prohibits the replacement of American workers by H-1B or L-1 visa holders. These provisions address the types of abuses that have been well-documented in recent press reports.

Democrat Zoe Lofgren -- who represents a Congressional district in California that includes Silicon Valley -- introduced 'The High-Skilled Integrity and Fairness Act of 2017'.

As soon as the bill, which proposes a skill and wage- based system for allocation of H-1B visas and seeks to more than double the minimum wage for an H-1B visa holder to USD 130,000, was introduced, stocks of major Indian information technology went down and rattled the USD 150-billion outsourcing industry.

"It's near-impossible to design an immigration system that selects only the highest-paid and still protects the inventiveness and meritocracy that has made Silicon Valley the centre of the tech world," said Ridhika Batra, US-head of the Federation of Indian Chambers of Commerce and Industries.

"Like all forms of protectionism, these measures by (the) US government would only lower standards and reduce productivity, eventually causing the US to lose the edge -- and the income -- that comes with being the undisputed champion of innovation," she said.

The bill among other things proposes setting aside 20 per cent of the annual allocation of H-1B visas for small and start-up employers with 50 or fewer employees.

Utah Republican Representative Jason Chaffetz, and his party colleague in the Senate Senator Mike Lee, have introduced identical bills in the House and the Senate -- Fairness for High-Skilled Immigrants Act of 2017 -- which proposes to eliminate the per-country immigration caps with a first-come-first-served system.

On February 2, Senator Sherrod Brown joined by Joe Donnelly and Kirsten Gillibrand, introduced the "End Outsourcing Act," which aims to ensure that federal contracts are awarded to companies who hire American workers.

Two Republican Senators Tom Cotton and David Perdue unveiled the Reforming American Immigration for Strong Employment (RAISE) Act on February 7, which proposes to lower overall immigration to 637,960 in its first year and to 539,958 by its tenth year -- a 50 per cent reduction from the 1,051,031 immigrants who arrived in 2015.

Cotton and Perdue met Trump at the White House on Tuesday, after which they said that H-1B and employment-based Green Card is likely to be reformed to attract the best and the brightest from across the world.

The White House yesterday said the Trump Administration has a natural desire to have a comprehensive look at the H-1B, spousal visa and students visas. Last week, Indian-American Congressman Ro Khanna joined a bipartisan group of three other lawmakers to table a legislation to reform the current H-1B and L1 work visas and end its abuse by foreign companies.

The bill, if passed by both the House and the Senate and signed into law by the US President, would require employers to make a good faith effort to recruit and hire American workers before bringing in foreign workers.

It also prohibits employers from replacing American workers with H-1B and L-1 workers or giving preference to H-1B visa holders when they are filling open positions. It will modify existing H-1B wage requirements, and establishes wage requirements for L-1 workers.

The bill proposes to prohibit employers from outsourcing H-1B and L-1 visa holders to other sites unless the employer obtains a waiver which is available only in limited circumstances when the rights of American workers are protected.

Congressional experts note that it might not be easy to pass a bill on H-1B visas unless there is a consensus or broader agreement on comprehensive immigration reform.

Batra said it is important to deal carefully the underlying shortage of STEM-skilled workers. According to a latest Brookings study by 2020, demand for skilled technologists will exceed the number of qualified applicants by 1 million, leaving USA vulnerable in key areas such as technological innovation, economic development and cybersecurity.

"Moving the allocation decision from an arbitrary process to a market-clearing auction should settle the debate over our economy's demand for skilled immigrant labour, and an incremental success in our highly controversial immigration debate might help break the immigration reform impasse in other areas, as well," Batra said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 24,2020

Kuala Lumpur, Feb 24: Malaysian Prime Minister Mahathir Mohamad has submitted his resignation to the king, two sources with direct knowledge of the matter told Reuters on Monday, amid talks of forming a new coalition to govern the country.

Mahathir, 94, assumed office in May 2018 for his second stint as prime minister.

A spokesman from the prime minister's office declined to comment, saying only that a statement will be issued soon.

The sources declined to be named as they were not authorised to talk to the media.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 5,2020

May 5: Global coronavirus deaths reached 250,000 on Monday after recorded infections topped 3.5 million, a news agency tally of official government data showed, although the rate of fatalities has slowed.

North America and European countries accounted for most of the new deaths and cases reported in recent days, but numbers were rising from smaller bases in Latin America, Africa and Russia.

Globally, there were 3,062 new deaths and 61,923 new cases over the past 24 hours, taking total cases to 3.58 million.

That easily exceeds the estimated 140,000 deaths worldwide in 2018 caused by measles, and compares with around 3 million to 5 million cases of severe illness caused annually by seasonal influenza, according to the World Health Organization (WHO).

While the current trajectory of COVID-19 falls far short of the 1918 Spanish flu, which infected an estimated 500 million people, killing at least 10% of patients, experts worry the available data is underplaying the true impact of the pandemic.

The concerns come as several countries begin to ease strict lockdowns that have been credited with helping contain the spread of the virus.

"We could easily have a second or a third wave because a lot of places aren't immune," Peter Collignon, an infectious diseases physician and microbiologist at Canberra Hospital, told Reuters. He noted the world was well short of herd immunity, which requires around 60% of the population to have recovered from the disease.

The first death linked to COVID-19 was reported on Jan. 10 in Wuhan, China after the coronavirus first emerged there in December. Global fatalities grew at a rate of 1-2% in recent days, down from 14% on March 21, according to the Reuters data.

DEATH RATE ANOMALIES

Mortality rates from recorded infections vary greatly from country to country.

Collignon said any country with a mortality rate of more than 2% almost certainly had underreported case numbers. Health experts fear those ratios could worsen in regions and countries less prepared to deal with the health crisis.

"If your mortality rate is higher than 2%, you've missed a lot of cases," he said, noting that countries overwhelmed by the outbreak were less likely to conduct testing in the community and record deaths outside of hospitals.

In the United States, around half the country's state governors partially reopened their economies over the weekend, while others, including New York Governor Andrew Cuomo, declared the move was premature.

In Britain, Prime Minister Boris Johnson, who battled COVID-19 last month, has said the country was over the peak but it was still too early to relax lockdown measures.

Even in countries where the suppression of the disease has been considered successful, such as Australia and New Zealand which have recorded low daily rates of new infections for weeks, officials have been cautious.

Australian Prime Minister Scott Morrison has predicated a full lifting of curbs on widespread public adoption of a mobile phone tracking app and increased testing levels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 28,2020

Canadian researchers are developing a DNA vaccine for SARS-CoV-2, the coronavirus that causes COVID-19 and has currently infected nearly 5,00,000 people worldwide and crippled the global economy.

Entos Pharmaceuticals, a health-care biotechnology company headed by a University of Alberta researchers, develop new therapeutic compounds using the company's proprietary drug-delivery platform and has begun manufacturing vaccine candidates against the novel coronavirus.

"Given the urgency of the situation, we can have a lead candidate vaccine within two months. Once we have that it's a race to get it into clinical trials," said John Lewis, CEO of Entos and a Professor at the University of Alberta in Canada.

Lewis said in comparison to a traditional vaccine, DNA-based vaccines hold several advantages.

Nucleic acids are introduced directly into the patient's own cells, causing them to make pieces of the virus--tricking the immune system into mounting a response without the full virus actually being present, the researcher said.

According to the company, the approach is recognised as being easier to move into large-scale manufacturing, offers improved vaccine stability and works without needing an infectious agent.

In the current absence of a vaccine for COVID-19, several companies around the world are mounting efforts to begin similar work.

The first clinical trial using a DNA-based vaccine developed by Moderna Inc.in the US on March 13.

Their approach allows for antibodies to be made in the human trial volunteers against a specific protein on the surface of the coronavirus that lets the virus enter human cells.

The hope is that the antibodies will stop the interaction.

Though this approach is designed to be effective against COVID-19 specifically, Lewis said Entos is taking a different tack.

The company plans to use plasmid DNA to amplify the production of key coronavirus surface and structural proteins with each injection, with an eye to the bigger picture.

"Many of the structural proteins in the virus are pretty well conserved across all the coronaviruses, including SARS and MERS," said Lewis.

"We're hoping that if we express more of the structural proteins that are common to most coronaviruses, we can inhibit the current COVID-19, and also potentially protect against all coronaviruses both past and future," Lewis added.

To move the project forward quickly, the company is seeking financial support from both provincial and federal levels of government.

"We have the opportunity to save a lot of lives, and I think it's really upon us and governments to find solutions for that," Lewis said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.